Tonix Pharmaceuticals stock halted ahead of FDA approval news
Evertec Inc . (NYSE:EVTC) shares reached a 52-week high of $38.32, reflecting a solid uptrend in the company’s stock value over the past year. The company’s strong fundamentals are evidenced by its perfect Piotroski Score of 9, according to InvestingPro data. Investors have shown increasing confidence in the payment services provider, propelling the stock to new heights. This peak comes amidst impressive fundamentals, including 17.4% revenue growth and a P/E ratio of 18.9x. The company has maintained dividend payments for 13 consecutive years, demonstrating consistent shareholder returns. InvestingPro analysis suggests the stock remains undervalued despite recent gains. The achievement of this 52-week high marks a significant milestone for Evertec, as it continues to expand its services and maintain a strong position in the financial technology sector. For deeper insights into EVTC’s valuation and growth prospects, check out the comprehensive Pro Research Report available on InvestingPro, which covers what really matters for informed investment decisions.
In other recent news, Evertec Inc. reported strong financial results for the first quarter of 2025, surpassing earnings and revenue forecasts. The company posted an adjusted earnings per share (EPS) of $0.87, exceeding the forecast of $0.79, and achieved revenue of $228.8 million, surpassing expectations of $217.97 million. This represents a year-over-year revenue increase of 11.4%, driven by growth in Latin America and technological advancements. Keefe, Bruyette & Woods analyst Vasundhara Govi raised the price target for Evertec to $44.00, highlighting the company’s strong execution and solid start to the year. The firm maintained its Outperform rating on Evertec, citing stable consumer spending in Puerto Rico and Latin America.
Evertec’s adjusted EBITDA rose by 14%, reflecting improved operational efficiency and cost management. The company’s liquidity position remained strong, with $460 million reported. Evertec has provided a positive outlook for 2025, with revenue guidance of $903-$911 million, representing growth of 6.8-7.7%. The company also anticipates adjusted EPS growth of 4.9-7.6% and an adjusted EBITDA margin between 39.5% and 40.5%.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.